chlorpromazine has been researched along with milnacipran in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashida, M; Ohno, Y; Uekusa, K | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for chlorpromazine and milnacipran
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for chlorpromazine and milnacipran
| Article | Year |
|---|---|
Forensic toxicological analyses of drugs in tissues in formalin solutions and in fixatives.
Topics: Adult; Antipsychotic Agents; Bromazepam; Chlorpromazine; Cyclopropanes; Drug Stability; Fixatives; Forensic Toxicology; Formaldehyde; Gas Chromatography-Mass Spectrometry; Humans; Kidney; Liver; Male; Methamphetamine; Methotrimeprazine; Milnacipran; N-Methyl-3,4-methylenedioxyamphetamine; Narcotics; Organ Preservation; Promethazine; Time Factors | 2015 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |